Related references
Note: Only part of the references are listed.Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes
Antonella Russo et al.
ADVANCED SCIENCE (2022)
Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients
Julie Mondet et al.
HEMATOLOGICAL ONCOLOGY (2020)
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer
Taekyoung Kwak et al.
CELL REPORTS (2020)
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes
Valentina Giudice et al.
CYTOKINE (2019)
Protective immunity by an engineered DNA vaccine for Mayaro virus
Hyeree Choi et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors
Leila J. Noetzli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma
Mao Huang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Megakaryocytes as immune cells
Pierre Cunin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
Satoshi Takagi et al.
CLINICAL CANCER RESEARCH (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Jie Zhou et al.
SEMINARS IN IMMUNOLOGY (2018)
In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells
Prakrith Vijey et al.
PLATELETS (2018)
Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells
Li Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment
Lisa U. Magnusson et al.
PROSTATE (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
Cora Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
Michaele B. Manigrasso et al.
SCIENTIFIC REPORTS (2016)
Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer
Jessica Nakhle et al.
ONCOIMMUNOLOGY (2016)
S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo
Bo Chen et al.
PLOS ONE (2015)
Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion
Monika Pruenster et al.
NATURE COMMUNICATIONS (2015)
Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9
Daren Low et al.
ONCOTARGET (2015)
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Anders Olsson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
Li Shen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Mechanisms of action of tasquinimod on the tumour microenvironment
E. Raymond et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Human S100A9 potentiates IL-8 production in response to GM-CSF or fMLP via activation of a different set of transcription factors in neutrophils
Jean-Christophe Simard et al.
FEBS LETTERS (2014)
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma
James Favaloro et al.
LEUKEMIA & LYMPHOMA (2014)
Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches
David Wong et al.
PLOS ONE (2014)
Myeloid-Derived Suppressor Cells in the Development of Lung Cancer
Myrna L. Ortiz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
John T. Isaacs et al.
CANCER RESEARCH (2013)
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections
Xianqiong Zou et al.
INFECTION AND IMMUNITY (2013)
Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
Indu R. Ramachandran et al.
JOURNAL OF IMMUNOLOGY (2013)
Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens
Steven M. Damo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
E. Van Valckenborgh et al.
LEUKEMIA (2012)
S100A9 Interaction with TLR4 Promotes Tumor Growth
Eva Kallberg et al.
PLOS ONE (2012)
Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts
Susan L. Dalrymple et al.
PROSTATE (2012)
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Roberto Pili et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Angiogenesis and Multiple Myeloma
Nicola Giuliani et al.
CANCER MICROENVIRONMENT (2011)
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
M. K. Brimnes et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Oxidative modifications of S100 proteins: functional regulation by redox
Su Yin Lim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Per Bjork et al.
PLOS BIOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
Saeid Ghavami et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells
D Viemann et al.
BLOOD (2005)
The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67(phox) and Rac-2
C Kerkhoff et al.
FASEB JOURNAL (2005)
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes
T Vogl et al.
BLOOD (2004)
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
MP Manitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes
IS Thorey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
